A kinase-defective transforming growth factor-ß receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cells

International Journal of Oncology

Volumn 12, Issue 1, 1998, Pages 87-94

  Ko, Yong ^a   Koli, Katrim ^b   Banerji, Sunandita S ^a   Li, Wenhui ^a   Zborowska, Elizabeth ^c   Willson, James K V ^c   Brattain, Michael G ^a   Arteaga, Carlos L ^b  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dominant negative inhibitor; kdT RII; MCF 7 cells; TGF ; Tumorigenicity

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR; MESSENGER RNA; PANCREATIC RIBONUCLEASE; PRIMER DNA; PROTEIN SERINE THREONINE KINASE; RETINOBLASTOMA PROTEIN; RNA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ARTICLE; BREAST CARCINOMA; CARCINOMA CELL; CELL GROWTH; CELL PROLIFERATION; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ENZYME DEFICIENCY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; ADENOCARCINOMA; ANIMAL; BREAST TUMOR; CANCER TRANSPLANTATION; CELL CULTURE; CELL CYCLE; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL CYCLE; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; NEOPLASM TRANSPLANTATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RETINOBLASTOMA PROTEIN; RIBONUCLEASE, PANCREATIC; RNA, MESSENGER; RNA, NEOPLASM; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0031974364     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Yingling JM, Wang XF and Bassing CH: Signaling by the transforming growth factor-ß receptors. Biochim Biophys Acta 1242: 115-136, 1995.
2. Miyazono K, Dijke PT, Ichijo H and Heldin CH: Receptors for transforming growth factor-ß. Adv Immunol 55: 181-220, 1994.
3. Wrana JL, Attisano L, Wieser R, Ventura F and Massague J: Mechanism of activation of the TGF-ß receptor. Nature 370: 341-347, 1994.
4. Yamashita H, ten Dijke P, Franzen P, Miyazono K and Heldin CH: Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor ß. J Biol Chem 269: 20172-20178, 1994.
5. Inagaki M, Moustakas A, Lin HY, Lodish MF and Carr BI: Growth inhibition by transforming growth factor ß(TGF-ß) type I is restored in TGFß-resistant hepatoma cells after expression of TGF-ß receptor type II cDNA. Proc Natl Acad Sci USA 90: 5359-5363, 1993.
6. Park KC, Kim SJ, Bang YJ, Park JG, Kim NK, Roberts AB and Sporn MB: Genetic changes in the transforming growth factor ß (TGF-ß) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-ß. Proc Natl Acad Sci USA 91: 8772-8776, 1994.
7. Kalkhoven E, Roelen BA Jr, De Winter JP, Mummery CL, van den Eijnden-van Raaij AJM, van der Saag PT and van der Burg B: Resistance to transforming growth factor ßand activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differ 6: 1151-1161, 1995.
8. Mazars P, Barboule N, Balsin V, Vidai B, Ducommun B and Valette A: Effects of TGF-ß1 (transforming growth factor-ß1) on the cell cycle regulation of human breast adenocarcinoma (MCF-7) cells. FEBS Lett 362: 295-300, 1995.
9. Vivien D, Attisano L, Wrana JL and Massague J: Signaling activity of homologous and heterologous transforming growth factor-ß receptor kinase complex. J Biol Chem 270: 7134-7141, 1995.
10. Sun LZ, Wu G, Willson JKV, Zborowska E, Yang J, Rajkarunanayake I, Wang J, Gentry LE, Wang XF and Brattain MG: Expression of transforming growth factor ß type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem 269: 26449-26455, 1994.
11. Wang J, Sun LZ, Myeroff L, Wang X, Gentry LE, Yang J, Liang J, Zborowska E, Markowitz S, Willson JKV and Brattain MG: Demonstration that mutation of the type II transforming growth factor ß receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem 270: 22044-22049, 1995.
12. Markowitz S, Wang J, Myeroff L, Parsons R, Sun LZ, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M and Willson JKV: Inactivation of the type II TGF-ß receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338, 1995.
13. Brattain MG, Markowitz SD and Willson JKV: The type II transforming growth factor-ß receptor as a tumor-suppressor gene. Curr Opin Oncol 8: 49-53, 1996.
14. Wieser R, Attisano L, Wrana JL and Massague J: Signaling activity of transforming growth factor ß type II receptors lacking specific domains in the cytoplasmic region. Mol Cell Biol 13: 7239-7247, 1993.
15. Bassing CH, Yingling JM, Howe DJ, Wang T, He WW, Gustafson ML, Shah P, Donahoe PK and Wang XF: A transforming growth factor ß type I receptor that signals to activate gene expression. Science 263: 87-89, 1994.
16. Wang J, Han W, Zborowska E, Liang J, Wang X, Willson JKV, Sun L and Brattain MG: Reduced expression of transforming growth factor ß type I receptor contributes to the malignancy of human colon carcinoma cells. J Biol Chem 271: 17366-17371, 1996.
17. Brattain MG, Ko Y, Banerji SS, Wu G and Willson JKV: Defects of TGFß receptor signaling in mammary cell tumorigenesis. J Mammary Gland Biol Neoplasia 1: 363-370, 1996.
18. Brand T, MacLellan WR and Schneider MD: A dominantnegative receptor for type ß transforming growth factors created by deletion of the kinase domain. J Biol Chem 268: 11500-11503, 1993.
19. Chen RH, Ebner R and Derynck R: Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-ß activities. Science 260: 1335-1338, 1993.
20. Zhao Y and Young SL: Requirement of transforming growth factor-ß (TGF-ß) type II receptor for TGF-ß-induced proliferation and growth inhibition. J Biol Chem 271: 2369-2372, 1996.
21. Mulder KM and Brattain MG: Effects of growth stimulatory factors on mitogenicity and c-myc expression in poorly differentiated and well differentiated human colon carcinoma cells. Mol Endocrinol 3: 1215-1222, 1989.
22. Gossen M and Bujard H: Tight control of gene expression in mammalian cells by tetracyclinc-responsive promoters. Proc Natl Acad Sci USA 89: 5547-5551, 1992.
23. Chirgwin JM, Przybyla AE, MacDonald RJ and Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5298, 1979.
24. Wu SP, Sun LZ, Willson JKV, Humphrey L, Kerbel R and Brattain MG: Repression of autocrine transforming growth factor ß1 and ß2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties. Cell Growth Differ 4: 115-123, 1933.
25. Gillies RJ, Didier N and Denton M: Determination of cell number in monolayer cultures. Anal Biochem 159: 109-113, 1986.
26. Brand T and Schneider MD: Inactive type II and type I receptors for TGFß are dominant inhibitors of TGFß-dependent transcription. J Biol Chem 270: 8274-8284, 1995.
27. Arteaga CL, Tandon AK, von Hoff DD and Osborne CK: Transforming growth factor ß: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res 48: 3898-3904, 1988.
28. Sherr CJ and Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9: 1149-1163, 1995.
29. Laiho M, De Caprio JA, Ludlow JW, Livingston DM and Massague J: Growth inhibition by TGF-ß linked to suppression of retinoblastoma protein phosphorylation. Cell 62: 175-185, 1990.
30. Kimchi A, Wang XF, Weinberg RA, Cheifetz S and Massague J: Absence of TGF-ß receptors and growth inhibitory responses in retinoblastoma cells. Science 240: 196-199, 1988.
31. Okamoto A, Jiang W, Kim SJ, Spillare EA, Stoner GD, Weinstein IB and Harris CC: Overexpression of human cyclin Dl reduces the transforming growth factor ß (TGF-ß) type II receptor and growth inhibition by TGF-ß1 in an immortalized human esophageal epithelial cell line. Proc Natl Acad Sci USA 91: 11576-11580, 1994.
32. Capocasale RJ, Lamb RJ, Vonderheid EC, Fox FE, Rook AH, Nowell PC and Moore JS: Reduced surface expression of transforming growth factor ß receptor type II in mitogen-activated T cells from Sezary patients. Proc Natl Acad Sci USA 92: 5501-5505, 1995.
33. Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Sensibar JA, Kim JH, Kalo M and Lee C: Genetic change in transforming growth factor ß (TGF-ß) receptor type I gene correlates with insensitivity to TGF-ß1 in human prostate cancer cells. Cancer Res 56: 44-48, 1996.
34. Wu SP, Theodorescu D, Kerbel RS, Willson JKV, Mulder KM, Humphrey LE and Brattain MG: TGF-ß1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector. J Cell Biol 116: 187-196, 1992.